Our Grant Process
The American Cancer Society funds innovative cancer research spanning basic, clinical, translational, and health equity science through peer-reviewed grants for investigators and institutions.
Funder: American Cancer Society
Due Dates: June 1, 2026 | December 1, 2026
Funding Amounts: Research Scholar Grants: up to $215,000/year (direct costs) + 10% indirect costs, up to 4 years; Institutional Research Grants: up to $120,000/year (new) or $100,000/year (renewal), 4 years; see mechanism-specific limits.
Summary: Funds cancer research across the continuum through multiple mechanisms, supporting independent investigators, early-career faculty, and institutions via a rigorous peer-review process.
Key Information: Eligibility windows and funding limits differ by mechanism; new deadlines and eligibility rules apply from 2025–2026 cycles.
Description
The American Cancer Society (ACS) offers a suite of competitive research funding opportunities targeting a broad spectrum of cancer research—from basic science to clinical, translational, population, and health equity studies. The ACS supports independent investigators, early-stage faculty, and institutions through various mechanisms, including Research Scholar Grants (RSG), Institutional Research Grants (IRG), Mission Boost Grants (MBG), Postdoctoral Fellowships (PF), and others. All proposals undergo rigorous, multi-tiered peer review and are managed through ProposalCentral.
